Pharmacorp Rx Inc. Financial Overview
Pharmacorp Rx Inc.'s market cap is currently C$69.44M. The company's EPS TTM is C$-0.004; its P/E ratio is 262.50; Pharmacorp Rx Inc. is scheduled to report earnings on November 28, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
